Cardiovascular Clinical Research
The University of Missouri Health System has conducted clinical trials for more than 40 years. Many of these trials have resulted in approval of new drugs from the Food and Drug Administration. The broad experience of our research team combined with our wide range of clinical opportunities makes the health system an attractive site for conducting clinical research.
Volunteers help speed future improvements in medical care to those in need. The University of Missouri Health System has a broad base of clinical trial opportunities available to volunteers such as you. Talk with your physician about participating in these trials.
To refer a patient to any cardiovascular medicine trial page the on-call pager number 573-499-8084.
Clinical Trials Currently Enrolling
Oral ion vs. Placebo-Oral iron repletion effects on oxygen uptake in heart failure
Apixaban vx. Warfarin – New-onset A-Fib with the intent to cardiovert. Must enroll prior to dosing with oral anticoagulant.
- Webel/Aggarwal/A. Kumar/A. Chan
Open label study to assess the long-term safety and efficacy of Evolocumab treatment for addtioanl LDL-cholesterol reduction.
Registry Trials Currently Enrolling
Post-market surveillance to document product performance assessment of Medtronic device leads
Ongoing Clinical Trials - Not Enrolling
Does inhibition of cholesteryl ester transfer protein (Anacetrapib vs. Placebo) prevent major vascular events in patients with vascular disease?
Late Sodium Current Blockade in High-Risk ICD patients using Ranolazine vs. Placebo
Canakinumab vs. Placebo in the prevention of recurrent cardiovascular events in Post-MI patients with elevated hsCRP
The Effects of AMG 145 vs. Placebo on Atherosclerotic disease burden as measured by IVUS in subjects undergoing coronary catheterization
Assessing the impact of additional LDL-C reduction on MACE when AMG 145 vs. Placebo is used in combination with statin therapy in patients with clinically evident CV disease